Detection of anti-HLA-F antibodies in sera from cancer patients

Anticancer Research

Volumn 24, Issue 5 C, 2004, Pages 3387-3392

  Noguchi, Katsuo ^a   Isogai, Manami ^a   Kuwada, Eri ^a   Noguchi, Atsutaka ^a   Goto, Shigenori ^b   Egawa, Kohji ^a,b  

^a Medinet Co Ltd   (Japan)

^b Seta Clinic   (Japan)

Author keywords

Cancer; HLA antibody

Indexed keywords

HLA ANTIBODY; HLA F ANTIBODY; HLA F ANTIGEN; IMMUNOGLOBULIN G; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; CANCER IMMUNOLOGY; CANCER PATIENT; CLINICAL ARTICLE; CONFERENCE PAPER; DIAGNOSTIC VALUE; FEMALE; GENE; HUMAN; MALE; PRIORITY JOURNAL; Q5 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; WESTERN BLOTTING;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODIES, NEOPLASM; FEMALE; GENE EXPRESSION; GENES, MHC CLASS I; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASMS; RECOMBINANT PROTEINS;

EID: 6344294614     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Watts S, Davis AC, Gaut B, Wheeler C, Hill L and Goodnow RS: Organization and structure of the Qa genes of the major histocompatibility complex of the C3H mouse: implications for Qa function and class I evolution. EMBO J 8: 1749-1759, 1989.
2. k mice. J Exp Med 175: 647-654, 1992.
3. Egawa K, Seo N, Tanino T and Tsukiyama T: Protection against metestasis by immunization with an allogeneic lymphocyte antigen. Cancer Immunol Immunother 41: 384-388, 1995.
4. Uchigiri C, Nizuno S, Wada K, Tsutsumi M, Kato T, Kamiya T and Ozawa K: An identification of the HLA-F null allele in Japanese. Immunogenetics 45: 466-467, 1997.
5. Wei X and Orr HT: Differential expression of HLA-E, HLA-F and HLA-G Transcripts in human tissue. Human Immunol 29: 131-142, 1990.
6. Houlihan JM, Andrew Biro P, Fergar-Payne A, Simpson KL and Holmes CH: Evidence for the expression of non-HLA-A, -B, -C class I genes in the human fetal liver. J Immunol 149: 668-675, 1992.
7. Amiot L, Onno M, Drenou B, Monvoisin C and Fauchet R: HLA-G class I gene expression in normal and malignant hematopoietic cells. Human Immunol 59: 524-528, 1998.
8. Lury D, Epstein H and Holmes N: The human class I MHC gene HLA-F is expressed in lymphocytes. Int Immunol 2: 531-537, 1990.
9. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL and McMichael AJ: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799, 1998.
10. Perez-Villar JJ, Melero I, Navarro F, Carretero M, Bellon T, Llano M, Colonna M, Geraghty DE and Lopez-Botet M: The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 158: 5736-5743, 1997.
11. Soderstrom K, Corliss B, Lanier LL and Phillips JH: CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol 159: 1072-1075, 1997.
12. O'Callaghan CA and Bell JI: Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev 163: 129-138, 1998.
13. Lepin EJM, Bastin JM, Allan DSJ, Roncador G, Braud VM, Mason DY, Anton van der Merwe P, Mcmichael AJ, Bell JI, Powis SH and O'Callaghan CA: Functional characterization of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol 30: 3552-3561.
14. Noguchi K, Kuwada E, Goto S and Egawa K: Tumor cell-specific transcription of a murine histocompatibility class Ib Q5 gene. Anticancer Res (In press).
15. Tanino T, Seo N, Okazaki T, Nakanishi-Ito C, Sekimata M and Egawa K: Detection of allogeneic Qa/TL and Ly specificities on murine tumor cells with IgD in tumor-regressor serum. Cancer Immunol Immunother 35: 230-236, 1992.